🇺🇸 Aranesp in United States

FDA authorised Aranesp on 17 September 2001

Marketing authorisations

FDA — authorised 17 September 2001

  • Application: BLA103951
  • Marketing authorisation holder: AMGEN
  • Status: supplemented

FDA

  • Status: approved

Aranesp in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in United States

Frequently asked questions

Is Aranesp approved in United States?

Yes. FDA authorised it on 17 September 2001; FDA has authorised it.

Who is the marketing authorisation holder for Aranesp in United States?

AMGEN holds the US marketing authorisation.